Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,574 | 81 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Nevro Corp. | $255.64 | 4 | $0 (2021) |
| GRT US Holding, Inc. | $234.80 | 4 | $0 (2022) |
| PFIZER INC. | $233.23 | 25 | $0 (2021) |
| Purdue Pharma L.P. | $161.63 | 12 | $0 (2018) |
| Daiichi Sankyo Inc. | $121.22 | 9 | $0 (2019) |
| Medtronic USA, Inc. | $105.57 | 4 | $0 (2020) |
| Medtronic, Inc. | $101.47 | 2 | $0 (2023) |
| Stimwave Technologies Incorporated | $78.91 | 2 | $0 (2022) |
| Allergan, Inc. | $51.23 | 3 | $0 (2022) |
| TerSera Therapeutics LLC | $45.27 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $29.28 | 2 | ABBVIE INC. ($16.06) |
| 2023 | $89.81 | 1 | Medtronic, Inc. ($89.81) |
| 2022 | $340.14 | 7 | GRT US Holding, Inc. ($234.80) |
| 2021 | $348.37 | 10 | Nevro Corp. ($241.40) |
| 2020 | $52.76 | 4 | Nevro Corp. ($14.24) |
| 2019 | $120.43 | 9 | TerSera Therapeutics LLC ($32.05) |
| 2018 | $308.89 | 31 | PFIZER INC. ($177.26) |
| 2017 | $284.61 | 17 | Purdue Pharma L.P. ($118.00) |
All Payment Transactions
81 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/29/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $16.06 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 05/22/2024 | TerSera Therapeutics LLC | Prialt (Drug) | Food and Beverage | In-kind items and services | $13.22 | General |
| Category: Pain Management | ||||||
| 03/18/2023 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $89.81 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 10/25/2022 | GRT US Holding, Inc. | Qutenza (Drug) | Food and Beverage | In-kind items and services | $20.22 | General |
| Category: Pain Management | ||||||
| 05/10/2022 | Nalu Medical, Inc. | Nalu Neurostimulation System (Device) | Food and Beverage | In-kind items and services | $16.39 | General |
| Category: Pain Management | ||||||
| 05/06/2022 | GRT US Holding, Inc. | Qutenza (Drug) | Food and Beverage | In-kind items and services | $197.00 | General |
| Category: Pain Management | ||||||
| 05/04/2022 | Stimwave Technologies Incorporated | StimQ Receiver Stimulator Kit Channel A US w/Receiver (Device), StimQ Freedom-4A Receiver Kit Channel A US w/ Receiver, StimQ Freedom-8A Receiver Kit Channel A US w/ Receiver | Food and Beverage | Cash or cash equivalent | $68.49 | General |
| Category: Neurostimulation | ||||||
| 03/01/2022 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $20.46 | General |
| Category: HYPERHYDROSIS | ||||||
| 01/21/2022 | GRT US Holding, Inc. | Qutenza (Drug) | Food and Beverage | In-kind items and services | $2.91 | General |
| Category: Pain Management | ||||||
| 01/20/2022 | GRT US Holding, Inc. | Qutenza (Drug) | Food and Beverage | In-kind items and services | $14.67 | General |
| Category: Pain Management | ||||||
| 08/23/2021 | Pacira Therapeutics, Inc. | Zilretta (Drug) | Food and Beverage | In-kind items and services | $14.85 | General |
| Category: Musculoskeletal | ||||||
| 07/28/2021 | Nevro Corp. | Omnia (Device) | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: Spinal Cord Stimulator | ||||||
| 07/20/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $11.66 | General |
| Category: NEUROSCIENCE | ||||||
| 06/25/2021 | Nevro Corp. | Omnia (Device) | Food and Beverage | In-kind items and services | $112.50 | General |
| Category: Spinal Cord Stimulator | ||||||
| 05/18/2021 | Nevro Corp. | Omnia (Device) | Food and Beverage | In-kind items and services | $112.55 | General |
| Category: Spinal Cord Stimulator | ||||||
| 04/14/2021 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $19.06 | General |
| Category: Opioid Analgesic | ||||||
| 04/06/2021 | PFIZER INC. | REYVOW (Drug) | Food and Beverage | In-kind items and services | $12.12 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 02/22/2021 | Pacira Therapeutics, Inc. | Zilretta (Drug) | Food and Beverage | In-kind items and services | $17.43 | General |
| Category: Musculoskeletal | ||||||
| 02/08/2021 | PFIZER INC. | — | Food and Beverage | In-kind items and services | $20.19 | General |
| 02/04/2021 | Medtronic, Inc. | VECTRIS (Device) | Food and Beverage | In-kind items and services | $11.66 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 12/14/2020 | BIODELIVERY SCIENCES INTERNATIONAL, INC. | — | Food and Beverage | In-kind items and services | $13.56 | General |
| 09/08/2020 | Medtronic USA, Inc. | INTELLIS (Device) | Food and Beverage | In-kind items and services | $12.83 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 07/15/2020 | PFIZER INC. | — | Food and Beverage | In-kind items and services | $12.13 | General |
| 02/18/2020 | Nevro Corp. | Senza Spinal Cord Stimulation System (Device) | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: Spinal Cord Stimulator | ||||||
| 12/17/2019 | Allergan Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $13.99 | General |
| Category: HYPERHYDROSIS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 152 | 275 | $86,503 | $19,219 |
| 2022 | 11 | 360 | 642 | $245,757 | $52,914 |
| 2021 | 15 | 658 | 860 | $435,488 | $82,053 |
| 2020 | 19 | 603 | 903 | $463,099 | $72,114 |
All Medicare Procedures & Services
68 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 37 | 64 | $10,048 | $5,237 | 52.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 29 | 55 | $8,635 | $3,669 | 42.5% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Facility | 2023 | 14 | 25 | $27,500 | $3,503 | 12.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 28 | 66 | $6,996 | $3,341 | 47.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 19 | 29 | $3,074 | $1,299 | 42.3% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Facility | 2023 | 14 | 25 | $27,500 | $1,086 | 4.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 11 | 11 | $2,750 | $1,083 | 39.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 57 | 128 | $20,296 | $10,920 | 53.8% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Facility | 2022 | 31 | 44 | $48,400 | $7,162 | 14.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 42 | 100 | $16,100 | $6,862 | 42.6% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Office | 2022 | 18 | 31 | $15,376 | $5,307 | 34.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 33 | 75 | $7,950 | $4,392 | 55.2% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Office | 2022 | 15 | 24 | $18,000 | $3,256 | 18.1% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Office | 2022 | 18 | 31 | $14,136 | $3,064 | 21.7% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Facility | 2022 | 13 | 23 | $11,408 | $2,283 | 20.0% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Facility | 2022 | 31 | 44 | $62,920 | $2,265 | 3.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 12 | 12 | $3,000 | $1,443 | 48.1% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Facility | 2022 | 13 | 23 | $10,488 | $1,314 | 12.5% |
| 62370 | Electronic analysis reprogramming and refill of spinal canal drug infusion pump by physician | Facility | 2022 | 26 | 38 | $7,562 | $1,299 | 17.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 16 | 26 | $2,931 | $1,156 | 39.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 12 | 12 | $3,000 | $1,094 | 36.5% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 11 | 15 | $3,150 | $769.61 | 24.4% |
| 77002 | Fluoroscopic guidance for needle placement | Office | 2022 | 12 | 16 | $1,040 | $326.42 | 31.4% |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2021 | 60 | 65 | $48,360 | $12,918 | 26.7% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2021 | 123 | 190 | $93,974 | $11,807 | 12.6% |
About Dr. Carol Mccourt, M.D
Dr. Carol Mccourt, M.D is a Anesthesiology healthcare provider based in Batesville, Arkansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1558337915.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Carol Mccourt, M.D has received a total of $1,574 in payments from pharmaceutical and medical device companies, with $29.28 received in 2024. These payments were reported across 81 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($1,574).
As a Medicare-enrolled provider, Mccourt has provided services to 1,773 Medicare beneficiaries, totaling 2,680 services with total Medicare billing of $226,299. Data is available for 4 years (2020–2023), covering 68 distinct procedure/service records.
Practice Information
- Specialty Anesthesiology
- Other Specialties Anesthesiology
- Location Batesville, AR
- Active Since 02/27/2006
- Last Updated 06/19/2015
- Taxonomy Code 207L00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1558337915
Products in Payments
- Omnia (Device) $241.40
- Qutenza (Drug) $234.80
- LYRICA (Drug) $180.06
- INTELLIS ADAPTIVESTIM (Device) $89.81
- SYNCHROMED (Device) $82.32
- Morphabond ER (Drug) $76.20
- HYSINGLA ER (Drug) $69.20
- StimQ Receiver Stimulator Kit Channel A US w/Receiver (Device) $68.49
- BOTOX (Biological) $67.29
- Zilretta (Drug) $50.68
- Movantik (Drug) $45.02
- OXYCONTIN (Drug) $41.97
- SYMPROIC (Drug) $39.00
- PRIALT (Drug) $32.05
- SUBSYS (Drug) $27.38
- Prialt (Drug) $25.97
- VECTRIS (Device) $22.08
- XTAMPZA (Drug) $19.06
- Nalu Neurostimulation System (Device) $16.39
- Senza Spinal Cord Stimulation System (Device) $14.24
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Anesthesiology Doctors in Batesville
Christopher Steel, Md, MD
Anesthesiology — Payments: $27,222
Dr. Todd Besselievre, M.d, M.D
Anesthesiology — Payments: $266.61
Wyatt Lydolph
Anesthesiology — Payments: $201.77
Dr. Sergio Bisono, M.d, M.D
Anesthesiology
Dr. Luis Flores, M.d, M.D
Anesthesiology
Enoch Brown, Md, MD
Anesthesiology